Differential effects of matrix and growth factors on endothelial and fibroblast motility: Application of a modified cell migration assay
Remco van Horssen(Erasmus MC Cancer Institute), Timo L.M. ten Hagen(Erasmus MC), Joost A.P. Rens(Erasmus MC), Alexander M.M. Eggermont(University Medical Center Utrecht), Niels Galjart(Erasmus MC)
Cited by 61
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k